Julien Meissonnier
Chief Tech/Sci/R&D Officer bij CATALENT, INC.
Profiel
Julien Meissonnier, oprichter van Accellix, Inc., is momenteel President & Directeur bij Accellix, Inc. en Chief Scientific Officer & Vice President bij Catalent, Inc., Chief Scientific Officer bij Catalent Pharma Solutions, Inc. (een dochteronderneming van Catalent, Inc.). Daarvoor was hij President & Chief Executive Officer van Cardio Ventures Ltd., Manager-Business Development bij Sol-Gel Technologies Ltd., Director-Marketing & Business Development bij Evogene Ltd., Manager-Global Marketing bij Novartis AG en Manager-Global Marketing bij Ciba-Geigy AG (een dochteronderneming van Novartis AG) en Development Engineer bij Rhône-Poulenc SA. Hij behaalde een diploma aan de Universiteit van Washington en een MBA aan INSEAD.
Actieve functies van Julien Meissonnier
Bedrijven | Functie | Begin |
---|---|---|
CATALENT, INC. | Chief Tech/Sci/R&D Officer | 19-11-2019 |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | Founder | 01-01-2009 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Chief Tech/Sci/R&D Officer | 01-10-2019 |
Eerdere bekende functies van Julien Meissonnier
Bedrijven | Functie | Einde |
---|---|---|
Cardio Ventures Ltd.
Cardio Ventures Ltd. Investment ManagersFinance Cardio Ventures Ltd is a venture capital firm. The firm headquartered in Jerusalem, Israel. | Chief Executive Officer | 01-01-2011 |
SOL-GEL TECHNOLOGIES LTD. | Corporate Officer/Principal | - |
NOVARTIS AG | Sales & Marketing | - |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Sales & Marketing | - |
EVOGENE LTD. | Sales & Marketing | - |
Opleiding van Julien Meissonnier
University of Washington | Graduate Degree |
INSEAD | Masters Business Admin |
École Nationale Supérieure d'Ingénieurs de Caen | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
NOVARTIS AG | Health Technology |
SOL-GEL TECHNOLOGIES LTD. | Health Technology |
EVOGENE LTD. | Health Technology |
CATALENT, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
Rhone-Poulenc SA | Process Industries |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Cardio Ventures Ltd.
Cardio Ventures Ltd. Investment ManagersFinance Cardio Ventures Ltd is a venture capital firm. The firm headquartered in Jerusalem, Israel. | Finance |